Just a few years ago researchers had naively hoped that they could design a drug to blast a single cancer-causing protein and send the disease into remission for years without forcing the patient to endure the side effects of prolonged toxic chemotherapy.
One notorious example came when just about every major drug company in the mid-1990s rushed to develop drugs to block a cancer-causing gene called ras.